Ten Trips

Once demonised and still largely illegal, psychedelic drugs are now officially a 'breakthrough therapy', used to treat depression, trauma and addiction and to enhance well-being. But as neuropsychologist Andy Mitchell shows in this deeply serious yet wildly entertaining investigation, this approach misses what is so strange and valuable about them: the psychedelic experience itself.

In Ten Trips he takes ten different drugs in ten different settings, journeying from a neuroimaging lab in London to the Colombian Amazon via Silicon Valley and his friend's basement kitchen. His encounters with scientists and gangsters, venture capitalists and con-men, psychonauts and shamans provide a panoramic view of psychedelics today: their capacity for healing but also trauma, for transcendence and corruption, profundity and hilarity.

By removing psychedelics from their indigenous and underground cultures, we risk losing the very things we need to harness them. To make them safe or normal might ultimately destroy what makes them potent. That potential is indeed great, not as an antidote to mental illness - none exists - but as a way of changing our whole perspective on mental health and flourishing.

Ten Trips is a dazzling, perception-shifting odyssey that shows how psychedelics can re-enchant us with the world.

Informacja dotycząca wprowadzenia produktu do obrotu:
Ten produkt został wprowadzony na rynek przed 13 grudnia 2024 r. zgodnie z obowiązującymi wówczas przepisami (Dyrektywą o ogólnym bezpieczeństwie produktów). W związku z tym może on być nadal sprzedawany bez konieczności dostosowania do nowych wymogów wynikających z Rozporządzenia o Ogólnym Bezpieczeństwie Produktów (GPSR). Produkt zachowuje pełną legalność w obrocie, a jego jakość i bezpieczeństwo pozostają zgodne z obowiązującymi wcześniej standardami.

Information regarding product placement on the market:
This product was placed on the market before December 13, 2024, in accordance with the applicable regulations at the time (the General Product Safety Directive). As a result, it can continue to be sold without needing to meet the new requirements introduced by the General Product Safety Regulation (GPSR). The product remains fully compliant with all previously valid legal standards, ensuring its continued quality and safety.